Yantai Xinkesida Pharmaceutical Technology Co., Ltd

Yantai Xinkesida Pharmaceutical Technology Co., Ltd. was established on March 31, 2022. It is a wholly-owned subsidiary of Dongcheng Pharmaceutical Group, one of the leading nuclear medicine enterprises in China. The company is mainly engaged in the research and development, production, and introduction of new foreign varieties of radioactive drug kits as production carriers in China.

The company has a total investment of 50 million yuan and is constructing a production line and supporting plant on the 3rd floor of Building A20 # at Yantai Muping International Medical Innovation Base. The plant is used for the cold box freeze-dried powder injection project for radioactive drugs. The plant is divided into four parts: research and development, QC laboratory, production workshop, and public systems. At present, an automated freeze-dried powder needle production line has been built in the workshop, equipped with fully automated equipment and facilities such as washing, drying, filling and rolling production linkage line, freeze dryer, injection water preparation system, etc., with an annual production capacity of 300000 pieces. The R&D area is used for the synthesis and small-scale testing of new products, while the QC laboratory is responsible for the testing and release of raw materials, intermediate products, and products.